AEON Biopharma, Inc. (AEON) — Working Capital to Net Assets Ratio
AEON Biopharma, Inc. (AEON) has a Working Capital to Net Assets ratio of 4.1% as of September 2025. Working capital of $-816.00K (current assets of $7.41 Million minus current liabilities of $8.23 Million) is measured against net assets of $-19.87 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See AEON defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
AEON Biopharma, Inc. Working Capital to Net Assets (2019–2024)
This chart shows how AEON Biopharma, Inc.'s Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 4.1%, reflecting working capital of $-816.00K against net assets of $-19.87 Million USD. For the complete balance sheet picture, see AEON current and non-current assets.
Annual Working Capital to Net Assets for AEON Biopharma, Inc. (2019–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for AEON Biopharma, Inc. from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check AEON financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 44.0% | $-12.56 Million | $-28.57 Million | $1.59 Million | $14.15 Million | ▲ +39.5 pp |
| 2023 | 4.5% | $-6.83 Million | $-153.04 Million | $6.22 Million | $13.05 Million | ▼ -22.4 pp |
| 2022 | 26.9% | $-72.74 Million | $-270.41 Million | $9.84 Million | $82.57 Million | ▲ +19.9 pp |
| 2021 | 7.0% | $-15.65 Million | $-223.82 Million | $5.15 Million | $20.80 Million | ▲ +15.0 pp |
| 2020 | -8.0% | $16.18 Million | $-203.23 Million | $20.38 Million | $4.20 Million | ▲ +135.7 pp |
| 2019 | -143.7% | $94.65 Million | $-65.87 Million | $112.14 Million | $17.50 Million | — |